BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 120 filers reported holding BIOSCRIP INC in Q3 2016. The put-call ratio across all filers is 0.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $27,000 | +350.0% | 10,438 | +485.1% | 0.00% | – |
| Q4 2018 | $6,000 | +100.0% | 1,784 | +104.4% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 873 | -2.9% | 0.00% | – |
| Q2 2018 | $3,000 | +200.0% | 899 | +16.0% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 775 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 775 | -1.6% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 788 | +1.7% | 0.00% | – |
| Q1 2016 | $2,000 | -99.5% | 775 | -99.2% | 0.00% | -100.0% |
| Q1 2015 | $441,000 | -36.6% | 99,518 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $696,000 | +1.2% | 99,518 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $688,000 | -18.3% | 99,518 | -1.4% | 0.00% | 0.0% |
| Q2 2014 | $842,000 | +37.8% | 100,918 | +15.2% | 0.00% | 0.0% |
| Q1 2014 | $611,000 | -18.9% | 87,569 | -14.0% | 0.00% | 0.0% |
| Q4 2013 | $753,000 | -93.0% | 101,770 | -91.6% | 0.00% | -94.1% |
| Q3 2013 | $10,699,000 | +51.6% | 1,218,489 | +184.9% | 0.02% | +30.8% |
| Q2 2013 | $7,056,000 | – | 427,637 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELberon, LLC | 2,334,000 | $5,952,000 | 11.88% |
| Alta Fundamental Advisers LLC | 2,250,000 | $5,738,000 | 7.23% |
| Coliseum Capital Management, LLC | 5,622,410 | $14,337,000 | 5.98% |
| WYNNEFIELD CAPITAL INC | 3,473,500 | $8,857,000 | 3.20% |
| First Light Asset Management, LLC | 2,092,082 | $5,335,000 | 2.47% |
| NORTH TIDE CAPITAL, LLC | 8,500,000 | $21,675,000 | 2.42% |
| ARDSLEY ADVISORY PARTNERS LP | 5,417,500 | $13,815,000 | 2.40% |
| Millrace Asset Group, Inc. | 543,862 | $1,387,000 | 2.26% |
| Keane Capital Partners, LLC | 271,100 | $691,000 | 1.64% |
| Monashee Investment Management LLC | 405,000 | $1,033,000 | 1.63% |